Promptly popping aspirin may be a life-saver for moderate COVID-19 patients

Embargoed until: Publicly released: 2022-03-25 02:00

International

People who took aspirin on their first day in hospital had lower odds of dying within a month than those who didn’t take aspirin, in a study of 112,269 Americans with moderate COVID-19. The relative reduction in death risk linked to aspirin was 13.6 per cent, and the effect was strongest among people older than 60, and those with health conditions. According to the authors, these findings warrant further study with a randomised clinical trial to establish whether or not the apparent link is causal.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page This link will be live at the embargo time

Journal/
conference: JAMA Network Open

Research:Paper

Organisation/s: George Washington University, University of Maryland, Walter Reed National Military Medical Center, Adams Cowley Shock Trauma Center (US)

Funder: The analyses described in this publication were conducted with data or tools accessed through the National Center for Advancing Translational Sciences (NCATS) N3C Data Enclave and supported by grant U24TR002306 from the NCATS. This study was also partially supported by grants NSF DEB-2028280 and DEB-2109688 from the National Science Foundation (Drs Rahnavard and Crandall) and 03UL1TR001876-05S1 from the NIH/NCATS (Dr Crandall), as well as an award from the George Washington University Office of the Vice President for Research (Dr Crandall). Role of the Funder/Sponsor: The funding sources had a role in the design and conduct of the study and collection, management, analysis, and interpretation of the data but not the preparation, review, or approval of the manuscript or decision to submit the manuscript for publication

Media Contact/s

Contact details are only visible to registered journalists.